Stefano Majocchi

Title: The Innovative Contributions of Stefano Majocchi

Introduction

Stefano Majocchi is a notable inventor based in Grand Lancy, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His work focuses on innovative solutions for treating diseases, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Stefano Majocchi holds a patent for bispecific antibodies against CEACAM5 and CD47. This invention provides bispecific antibodies that bind to human carcinoembryonic antigen CEACAM5 and human CD47. The patent also includes polynucleotides encoding such bispecific antibodies, as well as vectors and host cells that comprise these polynucleotides. Furthermore, the invention outlines methods for selecting and producing these antibodies, along with their applications in treating diseases both in monotherapy and in combination therapies. He has 1 patent to his name.

Career Highlights

Stefano Majocchi is currently associated with Lamkap Bio Beta Ltd., where he continues to push the boundaries of biotechnological research. His work at the company emphasizes the importance of innovative therapies in the medical field. His contributions are vital in the ongoing quest for effective treatments for various diseases.

Collaborations

Stefano collaborates with talented professionals in his field, including Vanessa Buatois and Klaus Strein. These collaborations enhance the research and development efforts at Lamkap Bio Beta Ltd., fostering an environment of innovation and creativity.

Conclusion

Stefano Majocchi's work exemplifies the spirit of innovation in biotechnology. His patent for bispecific antibodies represents a significant advancement in medical treatments. Through his career and collaborations, he continues to contribute to the betterment of healthcare solutions.